losartan has been researched along with Deficiency, Yin in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the effects of Jinshuibao Capsule (JC) combined losartan potassium on some indices of early renal damage of hypertension patients of yin and yang deficiency syndrome (YYDS), such as levels of serum cystatin C (Cys C), beta2-microglobulin (beta2-MG), hypersensitive C-reactive protein (hs-CRP), uric acid (UA), blood pressure, blood lipids, and fasting blood glucose (FBG), and to explore their protective effects on early renal damage of hypertension patients and on the metabolisms of blood lipids and blood glucose." | 9.17 | [Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research]. ( Ge, ZM; Wang, YQ; Xin, Q; Yin, JQ; Zhang, CQ, 2013) |
| "To observe the effects of Jinshuibao Capsule (JC) combined losartan potassium on some indices of early renal damage of hypertension patients of yin and yang deficiency syndrome (YYDS), such as levels of serum cystatin C (Cys C), beta2-microglobulin (beta2-MG), hypersensitive C-reactive protein (hs-CRP), uric acid (UA), blood pressure, blood lipids, and fasting blood glucose (FBG), and to explore their protective effects on early renal damage of hypertension patients and on the metabolisms of blood lipids and blood glucose." | 5.17 | [Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research]. ( Ge, ZM; Wang, YQ; Xin, Q; Yin, JQ; Zhang, CQ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, CQ | 1 |
| Yin, JQ | 1 |
| Xin, Q | 1 |
| Wang, YQ | 1 |
| Ge, ZM | 1 |
| Wu, F | 1 |
| Zhang, PQ | 1 |
| Wang, XQ | 1 |
| Nie, LF | 1 |
| Fu, XJ | 1 |
| Peng, W | 1 |
| Wang, Y | 1 |
| Li, J | 1 |
| Bi, YP | 1 |
| Mi, XH | 1 |
| Ding, XQ | 1 |
| He, LQ | 1 |
2 trials available for losartan and Deficiency, Yin
| Article | Year |
|---|---|
[Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research].
Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; C-Reactive Protein; Cystatin C; Drugs, Chinese Herbal | 2013 |
[Multi-center randomized control study on the effects of syndrome differentiated traditional Chinese medicine therapy on CKD 1-2 with chronic nephritis proteinuria].
Topics: Cell Differentiation; Drugs, Chinese Herbal; Glomerular Filtration Rate; Glomerulonephritis; Humans; | 2015 |